Cargando…

The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance

Ovarian cancer is the most lethal of all gynecologic malignancies and the eighth leading cause of cancer-related deaths among women worldwide. The main reasons for this poor prognosis are late diagnosis; when the disease is already in an advanced stage, and the frequent development of resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loret, Nele, Denys, Hannelore, Tummers, Philippe, Berx, Geert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628067/ https://www.ncbi.nlm.nih.gov/pubmed/31213009 http://dx.doi.org/10.3390/cancers11060838

Ejemplares similares

ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition
por: Skrypek, Nicolas, et al.
Publicado: (2018)

Cell Plasticity and Prostate Cancer: The Role of Epithelial–Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance
por: Papanikolaou, Sofia, et al.
Publicado: (2021)

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
por: Klymenko, Yuliya, et al.
Publicado: (2017)

The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells
por: Chung, Vin Yee, et al.
Publicado: (2019)

The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
por: Abaurrea, Andrea, et al.
Publicado: (2021)

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
por: De Wever, Olivier, et al.
Publicado: (2008)

Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2022)

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression
por: Berx, Geert, et al.
Publicado: (2001)

Contribution of Epithelial Plasticity to Therapy Resistance
por: Santamaría, Patricia G., et al.
Publicado: (2019)

Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
por: Sun, Nai-Yun, et al.
Publicado: (2020)

Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma
por: De Thaye, Elien, et al.
Publicado: (2020)

Risk of Thrombo-Embolic Events in Ovarian Cancer: Does Bevacizumab Tilt the Scale? A Systematic Review and Meta-Analysis
por: Saerens, Michael, et al.
Publicado: (2021)

Transcriptional census of epithelial-mesenchymal plasticity in cancer
por: Cook, David P., et al.
Publicado: (2022)

Editorial: Epithelial to Mesenchymal Plasticity in Colorectal Cancer
por: Bocci, Federico, et al.
Publicado: (2022)

Decoding cancer’s camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade
por: Lotsberg, Maria L., et al.
Publicado: (2020)

Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort
por: Van Damme, Axel, et al.
Publicado: (2023)

Epithelial–mesenchymal plasticity in carcinoma metastasis
por: Tsai, Jeff H., et al.
Publicado: (2013)

Metabolic Plasticity and Epithelial-Mesenchymal Transition
por: Thomson, Timothy M., et al.
Publicado: (2019)

Communication Between Epithelial–Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression
por: Zheng, Xiaobo, et al.
Publicado: (2021)

HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2023)

Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression
por: Foubert, Ellen, et al.
Publicado: (2010)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
por: Porter, Rebecca L., et al.
Publicado: (2019)

Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments
por: Calabrò, Maria Luisa, et al.
Publicado: (2020)

Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
por: Zhang, Lei, et al.
Publicado: (2019)

Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
por: Morone, Simona, et al.
Publicado: (2012)

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer
por: Pereira, Lloyd, et al.
Publicado: (2015)

Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer
por: Tsuchihashi, Kenji, et al.
Publicado: (2022)

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
por: Gu, Yuanzhuo, et al.
Publicado: (2023)

The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
por: Parafiniuk, Klaudia, et al.
Publicado: (2022)

Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries
por: Corallino, Salvatore, et al.
Publicado: (2015)

Research models and mesenchymal/epithelial plasticity of osteosarcoma
por: Yu, Xiaobin, et al.
Publicado: (2021)

Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression
por: Sulaiman, Andrew, et al.
Publicado: (2018)

The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
por: Lo, U-Ging, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

Intrinsic Balance between ZEB Family Members Is Important for Melanocyte Homeostasis and Melanoma Progression
por: Bruneel, Kenneth, et al.
Publicado: (2020)

HDAC Inhibition Impedes Epithelial-Mesenchymal Plasticity and Suppresses Metastatic, Castration-Resistant Prostate Cancer
por: Ruscetti, Marcus, et al.
Publicado: (2015)

HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
por: Xu, Long, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_udhs87gm1nebuulkbhhojo9p11